Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy-Reference-Cited by-同舟云学术

Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy

Published:2021-01 Issue: Volume:129 Page:70-77
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Roshan Reyhaneh,Naderi Shamsi,Behdani Mahdi,Cohan Reza Ahangari,Ghaderi Hajarsadat,Shokrgozar Mohammad Ali,Golkar Majid,Kazemi-Lomedasht Fatemeh

Funder

Pasteur Institute of Iran

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference46 articles.

1. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer;Liao;Oncotarget,2015

2. EpCAM (CD326) finding its role in cancer;Baeuerle;Br. J. Cancer,2007

3. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis;Spizzo;J. Clin. Pathol.,2011

4. Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy, Seminars in Oncology;Wargo,2015

5. An overview of targeted cancer therapy;Padma;BioMedicine,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing the cytotoxicity of immunotoxins by facilitating their dissociation from target receptors under the reducing conditions of the endocytic pathway;International Journal of Biological Macromolecules;2024-10

2. Development and characterization of nanobody against envenomation by Naja naja oxiana;Toxicon;2024-10

3. Targeted Delivery of Diphtheria Toxin into VEGFR1/VEGFR2 Overexpressing Cells Induces Anti-angiogenesis Activity;Current Protein & Peptide Science;2024-09

4. Advancements in ovarian cancer immunodiagnostics and therapeutics via phage display technology;Frontiers in Immunology;2024-05-28

5. Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line;Current Pharmaceutical Design;2024-05